Webinar recordings available on our YouTube channel
We’ve had twelve public webinars as part of our ongoing Mobilise-D webinar series, and it has been a great success! The recordings are available on our YouTube channel. The first…
We’ve had twelve public webinars as part of our ongoing Mobilise-D webinar series, and it has been a great success! The recordings are available on our YouTube channel. The first…
Who could have thought that, when we met at the Mobilise-D kick-off in April 2019, four years would pass before we were able to meet as a consortium again? Four…
We are tremendously proud to announce that the Mobilise-D Technical Validation Study has officially started recruiting subjects! After the unprecedented times of COVID-19 lock-down that affected the entire world, we…
In 2011, Stefanie Studenski presented her data on the powerful prediction of slow gait speed as an independent risk factor for mortality. This landmark paper raised the awareness of almost…
The work on algorithm development and technical validation has come to an end. We cannot believe it’s been three years already! The Mobilise-D webinar series on the Technical Validation Study…
We are very proud to announce that the Pulmonary Research Institute (PRI) in Grosshandorf, Schleswig-Holstein, Germany, is the first clinical site in our ongoing Clinical Validation Study that has reached…
Digital endpoints offer a great potential to be considered in the HTA framework. So far, however, there is no institutional way in. On February 15, 2021, IMI Neuronet hosted an online meeting of its working group on health technology assessment (HTA) and regulatory…
The Digital Health Catalyst (DHC) was created by Mobilise-D and IDEA-FAST in response to the growing need for research and application in the area of real-world digital measurements. “The field will…
Monitoring patients’ mobility during the COVID19 pandemic could easily have been impossible due to lockdown and restrictions such as social distancing. However, this isn’t the case for the Mobilise-D technical validation study (TVS) where 120 participants with chronic obstructive pulmonary disease, Parkinson’s disease, multiple sclerosis,…
The Mobilise-D Consortium is incredibly proud that our own WP2 star academic leader, Professor Claudia Mazzà from the University of Sheffield, is a recipient of the Suffrage Science award, celebrating…